Your session is about to expire
← Back to Search
Analgesic Properties of Oral Sucrose During Immunizations
N/A
Waitlist Available
Led By Linda A Hatfield, PhD
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, and then at 2 and 5 minutes post dtap, ipv, and hep b vaccine
Summary
The purpose of this study is to examine the analgesic properties of oral sucrose during routine immunizations. Hypothesis: Oral sucrose solution and maternal contact will significantly decrease the objective measures of acute pain during routine immunizations.
Eligible Conditions
- Procedural Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, and then at 2 and 5 minutes post dtap, ipv, and hep b vaccine
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, and then at 2 and 5 minutes post dtap, ipv, and hep b vaccine
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Behavioral pain response
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: SucroseExperimental Treatment1 Intervention
Participants received oral sucrose (0.6mL/Kg) 2 minutes prior to the combind DTaP, IPV, and Hep B (Hib and PCV7) vaccine.
Group II: PlaceboPlacebo Group1 Intervention
Participants received Placebo (sterile water, 0.6mL/Kg) 2 minutes prior to the combind DTaP, IPV, and Hep B (Hib and PCV7) vaccine.
Find a Location
Who is running the clinical trial?
Milton S. Hershey Medical CenterLead Sponsor
511 Previous Clinical Trials
2,870,762 Total Patients Enrolled
1 Trials studying Procedural Pain
140 Patients Enrolled for Procedural Pain
Linda A Hatfield, PhDPrincipal InvestigatorThe Penn State University